BlueStar Global Investors

BlueStar Global Investors is a financial research firm and index provider specializing in thematic and regional benchmarks, most notably the BlueStar Israel Global Index (BIGI). While not a biotechnology or pharmaceutical company, the firm is relevant to the life sciences sector through its development of the BlueStar Global Longevity & Healthcare Index, which tracks companies involved in biopharma, medical technology, and healthcare services. In August 2022, BlueStar was acquired by MarketVector Indexes, a subsidiary of VanEck, to expand its thematic index offerings. The company's indices serve as the basis for various exchange-traded funds (ETFs) and other investment products focused on innovation and healthcare. It provides market intelligence and benchmarking for investors looking to gain exposure to the Israeli capital markets and global healthcare themes.